Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	98.88	-55.71	-4993.55
Graham Fair Price	240.19	6.71	1.97
PEG	-99.63	< 0.005	2.10
Price/Book	14.48	21.57	18.84
Price/Cash Flow	-81.01	-41.08	216.27
Prices/Earnings	94.31	-11.20	-196.61
Price/Sales	138.38	53.52	22.45
Price/FCF	-81.01	-41.08	216.27
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.64	0.93	0.99
Operating Margin	-6531.00	-1.25	-0.02
ROA	-1567.79	-0.05	< 0.005
ROE	-0.02	-0.48	-1910.47
ROIC	-0.01	-0.07	-540.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.35	0.04	905.16
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.96	-23.42	2346.58
EPS QOQ	0.94	-14.24	1418.93
FCF QOQ	1.30	-5.62	332.40
Revenue QOQ	1.25	-0.63	-49.60
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	835.48	349.05	-58.22
Days Sales Outstanding (DSO)	27.12	3.87	-85.72
Inventory Turnover	0.11	0.26	139.36
Debt/Capitalization	0.79	0.86	8.70
Quick Ratio	5.42	6.75	24.51
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.69	2.04	-24.13
Cash	16.19	15.16	-6.36
Capex	< 0.005	-0.04	592.24
Free Cash Flow	0.23	-1.07	357.26
Revenue	2.25	0.82	-63.56
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.90	7.37	25.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-631.30	-11.26	98.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating